Viral hepatitis: Difference between revisions

No edit summary
Line 13: Line 13:
**HBsAg: + implies infection
**HBsAg: + implies infection
**Anti-HBs: implies clearance or vaccination
**Anti-HBs: implies clearance or vaccination
**Anti-HBc: Implies prior infection; IgM = acute & in flares; IgG always present
**Anti-HBc: Implies prior infection; IgM = acute & in flares; only marker in window period; IgG always present
**HBe-Ag: Implies active viral replication & infectivity
**HBe-Ag: Implies active viral replication & infectivity
**Anti-HBe: low infectivity
**HBV DNA: Similar to HBe-Ag but more sensitive
**HBV DNA: Similar to HBe-Ag but more sensitive



Revision as of 22:56, 20 February 2016

Background

Hepatitis A

  • Most common form of transmission occurs from asymptomatic children to adults
  • Incubation period: 15-50d
  • Prodrome: N/V, malaise, fever, abd pain
    • 1wk later bilirubinuria, clay-colored stool, jaundice
  • Death from hepatic failure is rare

Hepatitis B

  • Incubation period: 1-3 months
  • Presentation is similar to hep A
  • Lab tests:
    • HBsAg: + implies infection
    • Anti-HBs: implies clearance or vaccination
    • Anti-HBc: Implies prior infection; IgM = acute & in flares; only marker in window period; IgG always present
    • HBe-Ag: Implies active viral replication & infectivity
    • Anti-HBe: low infectivity
    • HBV DNA: Similar to HBe-Ag but more sensitive

Hepatitis C

  • Unlike Hep A and B, most often asymptomatic in acute phase of infection
  • >75% of pts advance to chronic stage
  • Active disease identified by reactive HCV ab and positive HCV RNA

Clinical Features

Acute Hepatitis Features

Jaundice of the skin
Pediatric jaundice with icterus of sclera.

Differential Diagnosis

Causes of acute hepatitis

Diagnosis

  • Hepatitis pannel

Treatment

Disposition

Admit Criteria

  • INR >2
  • Unable to tolerate POs
  • Pain control
  • Bilirubin >30
  • Hypoglycemia
  • Significant comorbid illness/immunocomp
  • >50 years

See Also

References

  1. Ostapowicz G, Fontana RJ, Schiodt FV, et al. Results of a prospective study of acute liver failure at 17 tertiary care centers in the United States. Ann Intern Med. 2002 Dec 17; 137(12): 947-54.